[HTML][HTML] The role of IL-23 in the pathogenesis and therapy of inflammatory bowel disease
A Korta, J Kula, K Gomułka - International Journal of Molecular Sciences, 2023 - mdpi.com
Interleukin-23 (IL-23) is a proinflammatory cytokine produced mainly by macrophages and
antigen-presenting cells (APCs) after antigenic stimulation. IL-23 plays a significant role as a …
antigen-presenting cells (APCs) after antigenic stimulation. IL-23 plays a significant role as a …
Cancer immunotherapy focusing on the role of interleukins; A comprehensive and updated study
M Samadi, A Kamrani, H Nasiri, N Shomali… - … -Research and Practice, 2023 - Elsevier
Cytokines bind to specific receptors on target cells to activate intracellular signaling
pathways that control diverse cellular functions, such as proliferation, differentiation …
pathways that control diverse cellular functions, such as proliferation, differentiation …
Mirikizumab: first approval
SJ Keam - Drugs, 2023 - Springer
Mirikizumab (Omvoh®), a humanized IgG4 anti-human IL-23p19 monoclonal antibody, is
being developed by Eli Lilly and Company Ltd for the treatment of ulcerative colitis and …
being developed by Eli Lilly and Company Ltd for the treatment of ulcerative colitis and …
Perspective insights of small molecules, phytoconstituents and biologics in the management of psoriasis: A focus on targeting major inflammatory cytokine pathways
H Kadagothy, S Nene, E Amulya, G Vambhurkar… - European Journal of …, 2023 - Elsevier
Psoriasis is an enduring, pruritic and papulosquamous skin ailment that poses a significant
burden on public health. It is mainly characterized by hyperkeratosis, acanthosis …
burden on public health. It is mainly characterized by hyperkeratosis, acanthosis …
Effect of curcumin on regulatory B cells in chronic colitis mice involving TLR/MyD88 signaling pathway
J Huang, T Wu, Y Zhong, J Huang, Z Kang… - Phytotherapy …, 2023 - Wiley Online Library
Curcumin (Cur) is a natural active phenolic compound extracted from the root of Curcuma
Longa L. It has anti‐inflammatory, anti‐tumor and other pharmacological activities, and is …
Longa L. It has anti‐inflammatory, anti‐tumor and other pharmacological activities, and is …
[HTML][HTML] Inflammatory Bowel Disease: From Conventional Immunosuppression to Biologic Therapy
A Sokic-Milutinovic, T Milosavljevic - Digestive Diseases, 2024 - karger.com
Background: Inflammatory bowel diseases (IBDs) are chronic, recurrent inflammatory
diseases with partly understood etiology and pathogenesis. The course of IBD, both …
diseases with partly understood etiology and pathogenesis. The course of IBD, both …
[HTML][HTML] A Narrative Review of Cytokine Networks: Pathophysiological and Therapeutic Implications for Inflammatory Bowel Disease Pathogenesis
M Vebr, R Pomahačová, J Sýkora, J Schwarz - Biomedicines, 2023 - mdpi.com
Inflammatory bowel disease (IBD) is a lifelong inflammatory immune mediated disorder,
encompassing Crohn's disease (CD) and ulcerative colitis (UC); however, the cause and …
encompassing Crohn's disease (CD) and ulcerative colitis (UC); however, the cause and …
[HTML][HTML] Nutraceuticals for the treatment of IBD: current progress and future directions
QY Ban, M Liu, N Ding, Y Chen, Q Lin, JM Zha… - Frontiers in …, 2022 - frontiersin.org
Inflammatory bowel disease (IBD) is a chronic relapsing-remitting inflammatory disease of
the gastrointestinal tract. Patients are usually diagnosed in adolescence and early …
the gastrointestinal tract. Patients are usually diagnosed in adolescence and early …
[HTML][HTML] Current status of novel biologics and small molecule drugs in the individualized treatment of inflammatory bowel disease
YH Xu, WM Zhu, Z Guo - World Journal of Gastroenterology, 2022 - ncbi.nlm.nih.gov
Abstract Treatment strategies for inflammatory bowel disease (IBD) are rapidly evolving with
the development of biologics and small molecule drugs (SMDs). However, these drugs are …
the development of biologics and small molecule drugs (SMDs). However, these drugs are …
[HTML][HTML] The role of IL-36 in the pathophysiological processes of autoimmune diseases
W Chen, X Yu, XR Yuan, B Chen, N Cai… - Frontiers in …, 2021 - frontiersin.org
A member of the interleukin (IL)-1 superfamily was IL-36, which contained IL-36α, IL-36β, IL-
36γ, and IL-36Ra. Heterotrimer complexes, consisting of heterodimeric receptor complexes …
36γ, and IL-36Ra. Heterotrimer complexes, consisting of heterodimeric receptor complexes …